ALS Canada announces The Shionogi Canada Fellowship for 2025
July 21, 2026
The ALS Society of Canada (ALS Canada) is pleased to continue its collaboration with Shionogi Canada (previously Tanabe Pharma Canada) to advance excellence in ALS clinical care through The Shionogi Canada Fellowship (previously the Tanabe Pharma Canada Fellowship). This annual…
Continue reading